Back to Search
MATTHEW LIPPMAN, PH.D.
PH.D.
Clinical Psychologist
NPI: 1750390878Individual
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
11336(NY)
Research & Publications (20)
Editorial: Cost-effective analyses in Breast Cancer Research and Treatment [corrected].
PMID 19449205·Breast Cancer Res Treat·2009
8-other
The androgen metabolite 5alpha-androstane-3beta,17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance.
PMID 18521740·Breast Cancer Res Treat·2009
8-other
A transcriptional fingerprint of estrogen in human breast cancer predicts patient survival.
PMID 18231641·Neoplasia·2008
8-other
An expression signature of estrogen-regulated genes predicts disease-free survival in tamoxifen-treated patients better than progesterone receptor status.
PMID 18596862·Trans Am Clin Climatol Assoc·2008
8-other
A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up.
PMID 17039267·Breast Cancer Res Treat·2007
8-other
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.
PMID 17157791·Cancer Cell·2006
8-other
GREB1 is a novel androgen-regulated gene required for prostate cancer growth.
PMID 16496412·Prostate·2006
8-other
Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors.
PMID 16606439·Genome Biol·2006
7-preclinical
New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK.
PMID 16773436·Breast Cancer Res Treat·2006
8-other
Knowledge mapping as a technique to support knowledge translation.
PMID 16917651·Bull World Health Organ·2006
8-other
Effect of raloxifene on the incidence of invasive breast cancer in postmenopausal women with osteoporosis categorized by breast cancer risk.
PMID 16951244·Clin Cancer Res·2006
8-other
GREB 1 is a critical regulator of hormone dependent breast cancer growth.
PMID 15986123·Breast Cancer Res Treat·2005
7-preclinical
A multicenter randomized clinical trial evaluating interleukin-2 activated hematopoietic stem cell transplantation and post-transplant IL-2 for high risk breast cancer patients.
PMID 16187232·Breast Cancer Res Treat·2005
3-trial
Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.
PMID 15908672·J Clin Oncol·2005
4-observational
(-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer.
PMID 15713891·Mol Cancer Ther·2005
7-preclinical
Consensus statement: Expedition Inspiration 2004 Breast Cancer Symposium 'Breast Cancer--The Development and Validation of New Therapeutics'.
PMID 15770520·Breast Cancer Res Treat·2005
8-other
Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment.
PMID 15841211·J Clin Invest·2005
7-preclinical
Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy.
PMID 15483018·J Clin Oncol·2004
3-trial
EGFR and EGFRvIII expression in primary breast cancer and cell lines.
PMID 15377854·Breast Cancer Res Treat·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1745 BROADWAY, 17 FL
NEW YORK, NY 10019 - Phone
- (212) 851-8100
Quick Facts
- NPI
- 1750390878
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile